On December 5, the Jiangxi Provincial Department of Industry and Information Technology and the Jiangxi Provincial Administration for Market Regulation jointly announced the list of winners for the third “Gan Chuxin Pin” awards. The “Extracorporeal Circulation Blood Line for Hemodialysis Devices” product of Jiangxi Hongda Medical Device Group Co., Ltd. was honored with this prestigious distinction, thanks to its cutting-edge technology and exceptional quality.

“The extracorporeal circuit for blood purification devices” is a key product of Hongda Group. During its research and development, the Group invested substantial human, material, and financial resources to enhance both the technological sophistication and clinical efficacy of the product. Earning the “Ganzhu Jingpin” designation this time represents recognition and reward for Hongda Group’s dedicated efforts in the medical device sector.

Hongda Group has consistently adhered to the corporate philosophy of “quality first,” rigorously controlling product quality to deliver safe, reliable, and highly effective solutions to patients. In the research, development, and manufacturing of its “extracorporeal blood circuit for hemodialysis devices,” Hongda Group has taken this principle to the utmost extent. By introducing state-of-the-art production equipment and technologies, coupled with stringent manufacturing processes and management systems, the company ensures that its products achieve world‑class levels of quality and performance.

As a medical device company with a strong commitment to innovation, Hongda Group has consistently dedicated itself to advancing technological breakthroughs and product development. The “Extracorporeal Circulation Blood Line for Hemopurification Devices,” which has been honored with the “Gan Chuxin Pin” title, represents a significant milestone in Hongda Group’s journey of innovation. This product not only boasts cutting-edge technology but has also delivered remarkable clinical outcomes, earning high praise from both experts and patients. It further underscores the widespread recognition of Hongda Group’s technical prowess and market competitiveness in the medical device sector.